These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6726884)

  • 1. Maternal drug use and fetal anomalies.
    Michalak D; Sanders RC
    J Ultrasound Med; 1984 May; 3(5):230, 234. PubMed ID: 6726884
    [No Abstract]   [Full Text] [Related]  

  • 2. Prenatal detection of multiple fetal anomalies following inadvertent exposure to cyclophosphamide in the first trimester of pregnancy.
    Paladini D; Vassallo M; D'Armiento MR; Cianciaruso B; Martinelli P
    Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):99-100. PubMed ID: 14991918
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prenatal diagnosis following teratogenic effects].
    Tews G; Arzt W; Hintermüller P
    Gynakol Rundsch; 1989; 29 Suppl 2():283-7. PubMed ID: 2693248
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pregnancy and antiepileptic agents; the value of prenatal ultrasonography studies for the detection of congenital malformations].
    Wladimiroff JW; Stewart PA; Reuss A; van Swaay E; Lindhout D; Sachs ES
    Ned Tijdschr Geneeskd; 1988 Aug; 132(32):1486-9. PubMed ID: 3050548
    [No Abstract]   [Full Text] [Related]  

  • 5. Antenatal sonography of fetal malformations associated with drugs and chemicals: a guide.
    Koren G; Edwards MB; Miskin M
    Am J Obstet Gynecol; 1987 Jan; 156(1):79-85. PubMed ID: 3541625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prescribing in pregnancy. Identifying abnormalities.
    Whittle MJ; Hanretty KP
    Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1485-8. PubMed ID: 3099923
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific sonographic exclusion diagnosis of fetal abnormalities in risk groups].
    Hansmann M; Gembruch U
    Gynakologe; 1984 Mar; 17(1):19-32. PubMed ID: 6202588
    [No Abstract]   [Full Text] [Related]  

  • 8. Teratogenesis.
    Harris JM; Pashayan HM
    Orthop Clin North Am; 1976 Apr; 7(2):281-9. PubMed ID: 1264426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of neural-tube defects in nonhuman primates.
    Michejda M; Hodgen GD
    Prog Clin Biol Res; 1985; 163B():243-7. PubMed ID: 2580314
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with a fetal dysmorphology/pathology service in an academic medical center.
    Sharony R; Hixon H; Pepkowitz SH; Carlson DE; Platt LD; Graham JM
    Birth Defects Orig Artic Ser; 1993; 29(1):219-33. PubMed ID: 8280875
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluconazole teratogenicity.
    Sanchez JM; Moya G
    Prenat Diagn; 1998 Aug; 18(8):862-3. PubMed ID: 9742580
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced embryopathy--case of multiple developmental anomalies in a newborn infant].
    Maszkiewicz W; Zaniewska J
    Pediatr Pol; 1974 May; 49(5):615-8. PubMed ID: 4830578
    [No Abstract]   [Full Text] [Related]  

  • 13. Congenital heart disease and extracardiac anomalies: associations and indications for fetal echocardiography.
    Copel JA; Pilu G; Kleinman CS
    Am J Obstet Gynecol; 1986 May; 154(5):1121-32. PubMed ID: 2939723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antenatal diagnosis for the clinician.
    Bombard AT
    J Miss State Med Assoc; 1988 Oct; 29(10):307-11. PubMed ID: 3230584
    [No Abstract]   [Full Text] [Related]  

  • 15. [Selected clinical aspects of modern teratology].
    Markiewicz C
    Wiad Lek; 1992 Feb; 45(3-4):120-5. PubMed ID: 1413791
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prenatal diagnosis in pregnant women with the toxic oil syndrome].
    Ramos C; Ayuso C; Palacios S; Bello MJ; Rey JA; Valcárcel E; Martínez P; Sánchez Cascos A
    Rev Clin Esp; 1983 May; 169(3):161-3. PubMed ID: 6612028
    [No Abstract]   [Full Text] [Related]  

  • 17. Etretinate and the risk for teratogenicity: drug monitoring in a pregnant woman for 9 months after stopping treatment.
    Vahlquist A; Rollman O
    Br J Dermatol; 1990 Jul; 123(1):131. PubMed ID: 2390493
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing diagnostic criteria for the fetal anticonvulsant syndromes.
    Dean JC; Moore SJ; Turnpenny PD
    Seizure; 2000 Apr; 9(3):233-4. PubMed ID: 10775521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal Hydantoin Syndrome.
    Hegde A; Kaur A; Sood A; Dhanorkar M; Varma HT; Singh G; Saini AG; Kumar P
    J Pediatr; 2017 Sep; 188():304. PubMed ID: 28578158
    [No Abstract]   [Full Text] [Related]  

  • 20. Results and pitfalls in prenatal cytogenetic diagnosis.
    Hsu LY; Dubin EC; Kerenyi T; Hirschhorn K
    J Med Genet; 1973 Jun; 10(2):112-9. PubMed ID: 4268389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.